Evidence map›Paper›PMID 38515699›Full record

ArticleHeliyon2024

Functional investigation of a novel

Shuoshuo Wei, Yanying Li, Wanling Yang, Shuxiong Chen, Fupeng Liu, Mei Zhang, Bo Ban, Dongye He

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Shuoshuo WeiDepartment of Endocrinology, Genetics and Metabolism, Affiliated Hospital of Jining Medical University, Jining, PR China.
Yanying LiDepartment of Endocrinology, Genetics and Metabolism, Affiliated Hospital of Jining Medical University, Jining, PR China.
Wanling YangDepartment of Paediatrics and Adolescent Medicine, The University of Hong Kong, PR China.
Shuxiong ChenDepartment of Endocrinology, Genetics and Metabolism, Affiliated Hospital of Jining Medical University, Jining, PR China.
Fupeng LiuDepartment of Endocrinology, Genetics and Metabolism, Affiliated Hospital of Jining Medical University, Jining, PR China.
Mei ZhangDepartment of Endocrinology, Genetics and Metabolism, Affiliated Hospital of Jining Medical University, Jining, PR China.
Bo BanDepartment of Endocrinology, Genetics and Metabolism, Affiliated Hospital of Jining Medical University, Jining, PR China.
Dongye HeDepartment of Endocrinology, Genetics and Metabolism, Affiliated Hospital of Jining Medical University, Jining, PR China.
Affiliated Hospital of Jining Medical University · CNChinese University of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

KBG syndrome is a rare autosomal dominant condition characterized by multisystem developmental disorder, primarily caused by loss-of-function variants in ankyrin repeat domain-containing protein 11 (ANKRD11). Approximately 80 % of

Indexed as

ANKRD11 geneFrameshift variantFunctional assaysKBG syndromeTruncated transcriptWhole-exome sequencing

Identifiers

PMID38515699
PMCPMC10956060
OpenAlexW4392768259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.